- Home
- SYTA vs ANEB Comparison
SYTA vs ANEB Comparison
Compare SYTA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- ANEB
- Stock Information
- Founded
- SYTA N/A
- ANEB 2020
- Country
- SYTA Canada
- ANEB United States
- Employees
- SYTA N/A
- ANEB N/A
- Industry
- SYTA Telecommunications Equipment
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- ANEB Health Care
- Exchange
- SYTA Nasdaq
- ANEB Nasdaq
- Market Cap
- SYTA 38.2M
- ANEB 39.0M
- IPO Year
- SYTA 2020
- ANEB 2021
- Fundamental
- Price
- SYTA $3.73
- ANEB $2.85
- Analyst Decision
- SYTA
- ANEB Buy
- Analyst Count
- SYTA 0
- ANEB 2
- Target Price
- SYTA N/A
- ANEB $8.00
- AVG Volume (30 Days)
- SYTA 2.1M
- ANEB 1.1M
- Earning Date
- SYTA 08-15-2025
- ANEB 09-24-2025
- Dividend Yield
- SYTA N/A
- ANEB N/A
- EPS Growth
- SYTA N/A
- ANEB N/A
- EPS
- SYTA N/A
- ANEB N/A
- Revenue
- SYTA $11,740,024.00
- ANEB N/A
- Revenue This Year
- SYTA $18.41
- ANEB N/A
- Revenue Next Year
- SYTA N/A
- ANEB N/A
- P/E Ratio
- SYTA N/A
- ANEB N/A
- Revenue Growth
- SYTA 33.58
- ANEB N/A
- 52 Week Low
- SYTA $0.93
- ANEB $0.80
- 52 Week High
- SYTA $53.64
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- SYTA 52.02
- ANEB 66.43
- Support Level
- SYTA $3.20
- ANEB $1.53
- Resistance Level
- SYTA $3.45
- ANEB $3.42
- Average True Range (ATR)
- SYTA 0.41
- ANEB 0.20
- MACD
- SYTA -0.12
- ANEB 0.05
- Stochastic Oscillator
- SYTA 34.12
- ANEB 69.84
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.